Breaking News on Global Pharmaceutical Technology & Manufacturing

Delivery formulations

News headlines

3D printing can save drug manufacturers time and money says UK expert

26-Apr-2016 - 3D printing can make drug production simpler and cheaper according to a UK expert who says using it for commercial production is about “numbering up” not scaling up.

Novartis aims to save $1bn by 2020 with integrated manufacturing plan

26-Apr-2016 - The savings will come from centralising manufacturing services and will complement the firm’s cost-saving business division launched last year.

PCI Synthesis sets up polymers development lab

20-Apr-2016 - API manufacturer PCI Synthesis has set up a polymer development group citing growing drug industry demand for advanced coating technologies and excipient technologies.

News in brief

Alembic Indian plant hit with US FDA Form 483 and four observations

19-Apr-2016 - The US FDA has hit an Indian formulation facility run by Alembic Pharmaceuticals with a Form 483 with four observations.

Lonza would add drug delivery tech through Catalent merger, analyst

14-Apr-2016 - Lonza acquiring Catalent would make “strategic sense,” according to an analyst as rumours circulate about a CMO megamerger.

Colorcon launches new coating for multiparticulate pills

13-Apr-2016 - Colorcon has launched a tablet coating system for multiparticulate dosage forms citing growing demand for such pills, particularly among the elderly.

European group responds to Indian proposal to replace gelatin in capsules

12-Apr-2016 - A European chemical industry group has reiterated that gelatin is safe after Indian regulators called for feedback on a plan to replace the excipient with cellulose in pharmaceutical capsules.

Allergan moves on with Heptares collaboration

11-Apr-2016 - After announcing it won’t acquire Pfizer last week, Allergan has announced a partnership with Heptares to advance medications for neurological disorders.

Pill attaches to GI tract lining for slow release

11-Apr-2016 - Researchers have developed a new tablet that attaches to the lining of the GI tract and slowly releases medication.

Catalent: Limited production begins at suspended French softgel plant

04-Apr-2016 - Catalent has missed its forecast for bringing a suspended softgel facility back online, but says production of essential drugs has begun at the French plant.

AC/DC's "Thunderstruck" key to new drug particle coating technique

01-Apr-2016 - Researchers in Australia are using a song by rock band AC/DC in a new coating process that they claim improves API delivery characteristics. 

Catalent softgel plant hit with US FDA 483 while client Opko receives CRL

31-Mar-2016 - The US FDA says it will not approve Opko's kidney disease drug Rayaldee until contract manufacturer Catalent fixes problems at its softgel plant in Florida.

Capsugel ripe to be sold or go public, investment banker

30-Mar-2016 - Rumours Capsugel owner KKR is mulling a sale or an IPO fit with the typical private equity investment cycles says expert.

First 3D printed medicine now available

29-Mar-2016 - The drug, manufactured by Aprecia Pharmaceuticals, is the first 3D printed prescription drug to receive US FDA approval.

Blu buy bolsters Puracap in US softgel market

29-Mar-2016 - Puracap has bought Blu Pharmaceuticals and its Puerto Rican manufacturing site and plans to double oral dose production capacity.

Sanofi goes to High Court over Indian ban on fixed dose combo diabetes drug

24-Mar-2016 - Sanofi has challenged an Indian Government decision banning the manufacture and sale of its fixed dose combination diabetes drug, Amaryl MP.

US FDA issues new labelling requirements for immediate-release opioids

24-Mar-2016 - The US FDA has ordered new labelling changes for immediate-release (IR) opioids but rejects claims that such products pose the same risks as extended-release (ER) opioids.

Meringue? No, you're not wrong: TxCell outlines unusual Ovasave delivery method

22-Mar-2016 - TxCell is working on new ways of delivering its Crohn's disease therapy Ovasave that will replace the somewhat unusual method it is using in clinical trials.

Braeburn plans $20m NC plant; awaits FDA decision on subdermal buprenorphine

22-Mar-2016 - Braeburn Pharmaceuticals will establish an R&D and manufacturing site in North Carolina for its subdermal implant candidate to treat opioid addiction.

Martindale removes povidone in oral methadone reformulation

21-Mar-2016 - Martindale Pharma will relaunch its opioid substitution therapy in Scandinavia after reformulating the oral solution to remove the excipient povidone.

Related News

Key Industry Events


Access all events listing

Our events, Shows & Conferences...

Product Innovation